These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 15733789)

  • 1. MR imaging of caveolin gene-specific alterations in right ventricular wall thickness.
    De Souza AP; Cohen AW; Park DS; Woodman SE; Tang B; Gutstein DE; Factor SM; Tanowitz HB; Lisanti MP; Jelicks LA
    Magn Reson Imaging; 2005 Jan; 23(1):61-8. PubMed ID: 15733789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caveolin-1 null (-/-) mice show dramatic reductions in life span.
    Park DS; Cohen AW; Frank PG; Razani B; Lee H; Williams TM; Chandra M; Shirani J; De Souza AP; Tang B; Jelicks LA; Factor SM; Weiss LM; Tanowitz HB; Lisanti MP
    Biochemistry; 2003 Dec; 42(51):15124-31. PubMed ID: 14690422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype.
    Park DS; Woodman SE; Schubert W; Cohen AW; Frank PG; Chandra M; Shirani J; Razani B; Tang B; Jelicks LA; Factor SM; Weiss LM; Tanowitz HB; Lisanti MP
    Am J Pathol; 2002 Jun; 160(6):2207-17. PubMed ID: 12057923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Right ventricular function in cardiovascular disease evaluated by magnetic resonance imaging].
    Imai H; Kobayashi S; Sakakibara M; Watanabe S; Masuda Y; Inagaki Y
    J Cardiol; 1988 Sep; 18(3):683-93. PubMed ID: 3249284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung remodeling and pulmonary hypertension after myocardial infarction: pathogenic role of reduced caveolin expression.
    Jasmin JF; Mercier I; Hnasko R; Cheung MW; Tanowitz HB; Dupuis J; Lisanti MP
    Cardiovasc Res; 2004 Sep; 63(4):747-55. PubMed ID: 15306231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Right ventricular involvement in hypertrophic cardiomyopathy.
    Maron MS; Hauser TH; Dubrow E; Horst TA; Kissinger KV; Udelson JE; Manning WJ
    Am J Cardiol; 2007 Oct; 100(8):1293-8. PubMed ID: 17920373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts.
    Cohen AW; Park DS; Woodman SE; Williams TM; Chandra M; Shirani J; Pereira de Souza A; Kitsis RN; Russell RG; Weiss LM; Tang B; Jelicks LA; Factor SM; Shtutin V; Tanowitz HB; Lisanti MP
    Am J Physiol Cell Physiol; 2003 Feb; 284(2):C457-74. PubMed ID: 12388077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations.
    Germans T; Wilde AA; Dijkmans PA; Chai W; Kamp O; Pinto YM; van Rossum AC
    J Am Coll Cardiol; 2006 Dec; 48(12):2518-23. PubMed ID: 17174192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of caveolin-1 leads to enhanced nitrosative stress and severe systolic and diastolic heart failure.
    Wunderlich C; Schober K; Lange SA; Drab M; Braun-Dullaeus RC; Kasper M; Schwencke C; Schmeisser A; Strasser RH
    Biochem Biophys Res Commun; 2006 Feb; 340(2):702-8. PubMed ID: 16380094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade.
    Woodman SE; Park DS; Cohen AW; Cheung MW; Chandra M; Shirani J; Tang B; Jelicks LA; Kitsis RN; Christ GJ; Factor SM; Tanowitz HB; Lisanti MP
    J Biol Chem; 2002 Oct; 277(41):38988-97. PubMed ID: 12138167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice.
    Zhao YY; Liu Y; Stan RV; Fan L; Gu Y; Dalton N; Chu PH; Peterson K; Ross J; Chien KR
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11375-80. PubMed ID: 12177436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR imaging of cardiomyopathy.
    Park JH; Kim YM
    Magn Reson Imaging Clin N Am; 1996 May; 4(2):269-86. PubMed ID: 8724566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertrophic cardiomyopathy with dominant hypertrophy in the right anterobasal region of the ventricular septum: a case report.
    Matsubara T; Yamazoe M; Kimura M; Hori T; Ozaki K; Hatada K; Aizawa Y
    J Cardiol; 2000 Jul; 36(1):45-8. PubMed ID: 10929265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The adverse cardiopulmonary phenotype of caveolin-1 deficient mice is mediated by a dysfunctional endothelium.
    Wunderlich C; Schober K; Schmeisser A; Heerwagen C; Tausche AK; Steinbronn N; Brandt A; Kasper M; Schwencke C; Braun-Dullaeus RC; Strasser RH
    J Mol Cell Cardiol; 2008 May; 44(5):938-47. PubMed ID: 18417152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive transthoracic cardiac imaging in mice using ultrasound biomicroscopy with anatomical confirmation by magnetic resonance imaging.
    Zhou YQ; Foster FS; Nieman BJ; Davidson L; Chen XJ; Henkelman RM
    Physiol Genomics; 2004 Jul; 18(2):232-44. PubMed ID: 15114000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiomyopathy in Friedreich's ataxia-assessment by cardiac MRI.
    Meyer C; Schmid G; Görlitz S; Ernst M; Wilkens C; Wilhelms I; Kraus PH; Bauer P; Tomiuk J; Przuntek H; Mügge A; Schöls L
    Mov Disord; 2007 Aug; 22(11):1615-22. PubMed ID: 17546670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.
    Jasmin JF; Mercier I; Dupuis J; Tanowitz HB; Lisanti MP
    Circulation; 2006 Aug; 114(9):912-20. PubMed ID: 16940204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed enhancement on cardiac magnetic resonance and clinical, morphological, and electrocardiographical features in hypertrophic cardiomyopathy.
    Satoh H; Matoh F; Shiraki K; Saitoh T; Odagiri K; Saotome M; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H
    J Card Fail; 2009 Jun; 15(5):419-27. PubMed ID: 19477402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed enhancement in hypertrophic cardiomyopathy: comparison with myocardial tagging MRI.
    Kim YJ; Choi BW; Hur J; Lee HJ; Seo JS; Kim TH; Choe KO; Ha JW
    J Magn Reson Imaging; 2008 May; 27(5):1054-60. PubMed ID: 18425835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caveolin-1 deficiency increases cerebral ischemic injury.
    Jasmin JF; Malhotra S; Singh Dhallu M; Mercier I; Rosenbaum DM; Lisanti MP
    Circ Res; 2007 Mar; 100(5):721-9. PubMed ID: 17293479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.